PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $512,000 | -41.4% | 163,100 | -37.8% | 0.07% | -35.2% |
| Q1 2016 | $873,000 | +106.9% | 262,100 | +119.9% | 0.10% | +98.1% |
| Q4 2015 | $422,000 | -6.4% | 119,200 | +32.9% | 0.05% | -13.1% |
| Q3 2015 | $451,000 | -6.0% | 89,659 | +20.2% | 0.06% | -25.6% |
| Q2 2015 | $480,000 | -4.8% | 74,600 | +4.2% | 0.08% | -38.8% |
| Q1 2015 | $504,000 | +350.0% | 71,581 | +377.2% | 0.13% | +74.0% |
| Q3 2014 | $112,000 | -32.5% | 15,000 | -12.8% | 0.08% | -31.2% |
| Q2 2014 | $166,000 | – | 17,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |